e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD – therapy/exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gram-negative enterobacteria in the etiological structure of COPD exacerbation
E. Mishustina, T. Ageeva, S. Mishustin (Tomsk, Russian Federation)
Source:
Annual Congress 2006 - COPD – therapy/exacerbations
Session:
COPD – therapy/exacerbations
Session type:
E-Posters in free access
Number:
305
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Mishustina, T. Ageeva, S. Mishustin (Tomsk, Russian Federation). Gram-negative enterobacteria in the etiological structure of COPD exacerbation. Eur Respir J 2006; 28: Suppl. 50, 305
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The role of bacterial infections in COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 298s
Year: 2005
Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Pseudomonas aeruginosa
drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001
Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009
Causative bacteria in protracted bacterial bronchitis are biofilm forming species
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
Bacterial infections in COPD
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008
What is bacterial colonisation in COPD?
Source: Eur Respir Monogr 2015; 69: 161-171
Year: 2015
A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
The role of bacteria in COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014
The impact of pseudomonas aeruginosa in the sputum of patients presenting with acute COPD exacerbation
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
The etiology and antimicrobial drugs resistance of microorganisms in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 2s
Year: 2006
Epidemiology, treatment and outcomes of nosocomial pneumonia due to Gram-negative bacteria
Source: Eur Respir J 2007; 30: Suppl. 51, 408s
Year: 2007
Antibiotics reduce dual pathogen isolates more than single pathogen isolates following COPD exacerbation
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009
The role of bronchial bacterial infection/colonization in acute exacerbation of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Bacterial infections in patients with acute exacerbations of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004
Structure of the basic pathogens of bacterial bronchitis and pneumonia in hospitalized patients in Belarus
Source: Eur Respir J 2006; 28: Suppl. 50, 4s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept